Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
New York City Gets Its HIV Act Together

High proportions of New York City residents with human immunodeficiency virus (HIV) infection are being diagnosed, receiving care, and seeing their serum viral load plummet to undetectable levels, city health officials reported here.

Published
4 hours ago
From
MedPage Today HIV/AIDS
Financial incentives did not improve linkage to care or viral suppression in US study

A US study which offered patients gift cards to present themselves for care after testing, and also to stay in care and maintain an undetectable viral load,

Published
28 February 2015
By
Gus Cairns
Gilead avoids billions in U.S. taxes on its $1,000-a-pill drug

Gilead Sciences Inc., whose $1,000-a-pill hepatitis C treatment is one of the world's most expensive drugs, is avoiding billions of dollars in U.S. taxes by booking profits overseas.

Published
27 February 2015
From
Chicago Tribune
HIV Prevention Cuts Medical Costs

Averting a single infection could save up to $338,000 over a lifetime.

Published
27 February 2015
From
MedPage Today HIV/AIDS
Treatment cascades and viral load surveys show how African countries can maximise prevention benefits of HIV treatment

Reaching ambitious HIV prevention targets in South Africa will require intensified efforts to engage and retain men and young people in care, in order to increase the

Published
27 February 2015
By
Keith Alcorn
CROI 2015: Trial to evaluate the use of health navigators to link HIV/TB patients to care and treatment fails to show positive results

Patients randomized to the support of a health navigator were not more likely than those who received standard of care to complete tuberculosis treatment or begin antiretroviral therapy within three months of HIV diagnosis, according to the results of a South African randomized trial presented here today.

Published
26 February 2015
From
Science Speaks
Financial incentives can influence control of HIV in some clinical settings

After financial incentives had been in effect for 18 months, the number of patients who achieved viral suppression, overall, was five percent higher at sites using financial incentives compared to those not offering the incentives. Additionally, viral suppression was 11 percent higher at sites with a smaller number of patients and 13 percent higher at sites with fewer patients having an undetectable viral load at the beginning of the study.

Published
26 February 2015
From
Eurekalert Medicine & Health
HIV and LGTB NGOs and other concerned actors across Europe call for futher action on pre-exposure prophylaxis

The European AIDS Treatment Group (EATG), Europe’s network of HIV activists, and  AIDES, a leading French NGO in the fight against AIDS and viral hepatitis, backed by 81 European HIV LGBT civil society organisations and concerned actors, issued an urgent HIV Prevention Manifesto today. We demand that pre-exposure prophylaxis for HIV (PrEP) is made available as soon as possible within the European Union, and that Gilead, the company that makes the PrEP medicine Truvada®, submits an application to the European Medicines Agency (EMA) for a change of indication so that its use to prevent HIV can be approved.

Published
25 February 2015
From
EATG
'Give HIV drugs to healthy gay men'

Healthy gay men should be offered daily HIV drugs to prevent infections, say UK Medical Research Council and Public Health England scientists. Their study, on 545 high-risk men, found one case of HIV could be stopped for every 13 men treated for a year. The research team says it would be similar to the pill for women and would not encourage risky sex. The findings have been described as a "game changer" and the NHS is considering how to adopt them.

Published
25 February 2015
From
BBC News
Pre-exposure prophylaxis (PrEP) stops 86% of HIV infections in PROUD study

A study of pre-exposure prophylaxis (PrEP), the English PROUD study, demonstrated the highest effectiveness yet seen for this method of HIV prevention, the Conference on Retroviruses and

Published
24 February 2015
By
Gus Cairns
← First12345...469Next →

Filter by country